. For human breast carcinomas, tumour take is generally low, about 6-15% (Rae-Venter and Reid. 1980 : Fogh et al.. 1982 Giovanella et al., 1989 Giovanella et al., , 1991 . Recently. we achieved significant success in establishing human breast tumour xenograft lines in athymic mice (Mehta et al.. 1993) . Enzyme-dispersed tumours were mixed with Matnrgel (a mixture of basement membrane components), then injected subcutaneously (s.c.) into athymic mice. Matrigel use not only increased tumour take, but also enhanced tumour growth and facilitated distant metastasis (Mehta et al., 1993) .
The initial establishment and subsequent growth of a solid tumour results from successful interaction between tumour cell basement membranes and surrounding stromal components. Expansion and metastasis of primary tumours depend on angiogenesis (Gimbrone et al.. 1972; Furcht. 1986) . Basement membrane components, especially laminin and various growth factors, are directly involved in tumour angiogenesis (Folkman. 1972 : Sakamoto et al.. 1991 : Yamamura et al., 1993 .
Matrigel is a mixture of various components. containing mainly laminin (56%), collagen IV (31%). heparan sulphate (5%) and entactin (8%). It also contains various growth factors generally present in basement membrane (Sabiston et al., 1985; Passaniti et al., 1992) . Matrigel and laminin enhance the tumour take and promote growth of various human tumour types (Pretlow et al.. 1991; Yamamura et al., 1993) . Laminin also promotes tumour cell adhesion, cell migration and invasion and metastasis (Barsky et al., 1984; Terranova et al.. 1984 : Fridman et al., 1990 . 1991 Kleinman et al., 1991) . However, in addition to factors associated with basement membrane and stroma, the original tumours' characteristics associated with tumour aggressiveness may also modulate the in vivo tumour take in experimental animals. Overexpression amplification or mutation of various oncogenes. especially c-erbB-2 and p53. not only alters expression of various receptors binding to basement membrane components, but also enhances metastatic potential (Liotta et al., 1986; Taylor et al.. 1992; Yu et al., 1992; D'Souza et al., 1993) .
In tumours. 17 (60.700) developed palpable xenografts at the site of injection. All 17 xenografts retained the same histological characteristics as the primary tumour from which they were derived. Metastasis to distant organs was frequently (33-66%) observed after s.c. transplantation into athymic mice of original patients' tumours or established xenografts. The incidence of metastasis increased during serial transplantation of xenografts (data not shown). Six of 17 (35.3%) xenografts showed metastatic lesions at various in vivo passaging in the lung. Distant metastasis was confirmed by histological examination of suspected lesions. The incidence of metastases was higher in xenografts originating from tumours of premenopausal women (5 8. 62.5'o) than in those from postmenopausal woman (2 9. 22.2 0o ).
Discussion
We achieved significant success in establishing human breast carcinoma xenografts in athvrmic mice using Matrigel. a mixture of reconstituted basement membrane. Seventeen of 28 breast tumours transplanted s.c. developed continuously transplantable xenograft lines. The incidence of breast tumour take in our study is significantly higher than that reported by other investigators (generally 6-15%) (RaeVenter and Reid. 1980: Fogh et al.. 1982; Giovanella et al.. 1989 Giovanella et al.. . 1991 .
For continued growth of solid malignant tumour. induction of angiogenesis is essential (Gimbrone et al.. 1972) . In the absence of neovascularisation, tumour nodules fail to grow larger than a few millimetres in diameter (Gimbrone et al.. 1972) . Recently, laminin and various growth factorsespecially transforming growth factor beta (TGF-P) and basic fibroblast growth factor (BFGF) have been shown to play an important role in angiogenesis (Sakamoto et al.. 1991 : Yamamura et al.. 1993 ). Cys-Asp-Pro-Gly-Tyr-Ile-Gly-SerArg-NH2 (CDPGYIGSR-NH2). a laminin-denrved polypeptide containing an active site for cell binding, inhibited both angiogenesis and solid tumour growth (Sakamoto et al.. 1991; Yamamura et al.. 1993) . In vivo. CDPGYIGSR-NH' inhibited the growth of subcutaneously transplanted solid sarcoma tumour and Lewis lung carcinoma (Yamamura et al.. 1993) . The effect of this peptide in these animals was not direct. but was mediated through its angiogenesis inhibitory influence (Yamamura et al.. 1993) . In the study reported herein, significantly high tumour take of human breast carcinomas, irrespective of their original histopathological subtypes, may partly result from induction of angiogenesis by components present in Matrigel.
In addition to higher tumour take. we also observed frequent (7 17. 41.2%) distant metastasis following s.c. transplantation of xenografts into animals. Most of these tumours were from premenopausal women and expressed high levels of p53 and c-erbB-2 proteins.
Possibly. during serial in vivo transplantation of tumours. only selective highly aggressive tumours grow successfully. 
